Edvard A.
- Country
- Sweden
- Department
- Onkologikliniken
Research Overview
- Biomarker-Driven Targeted Therapy in Advanced Cancer: A Swedish Nationwide Clinical Trial (FOCU.SE)
- Phase 3 Randomized Double-Blind Study of Talazoparib and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
- Evaluation of Safety and Efficacy of Divarasib with Pembrolizumab and Chemotherapy in KRAS G12C Mutant Advanced Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 38 of 116 partner sites.
Specializations
Oncology Focus
Specializes in treating advanced cancers with particular emphasis on metastatic castration-resistant prostate cancer and advanced solid tumors. The investigator explores innovative therapeutic approaches using targeted antibody treatments and novel radiopharmaceuticals.
- Prostate Cancer Therapeutics
- Solid Tumor Treatment
- Colorectal Cancer Management
- Non-Small Cell Lung Cancer
Cardiovascular Medicine
Focuses on cardiovascular conditions with particular interest in abdominal aortic aneurysm management and dyslipidemia treatment. Investigates therapeutic approaches for acute myocardial conditions.
- Aortic Aneurysm Treatment
- Lipid Management
- Myocardial Infarction Care
Metabolic Disorders
Conducts research in metabolic diseases with expertise in Type 2 Diabetes treatment modalities. Investigates comparative effectiveness of various therapeutic approaches including SGLT2 inhibitors and metformin.
- Diabetes Management
- Metabolic Disease Treatment
- Drug Therapy Optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.